Literature DB >> 2085431

The discovery of the vinca alkaloids--chemotherapeutic agents against cancer.

R L Noble1.   

Abstract

In folklore medicine, extracts of the leaves of the subtropical plant Catharanthus roseus (L.) G. Don (sometimes known as Madagascar periwinkle) were reputed to be useful in the treatment of diabetes. This review describes how attempts to verify the antidiabetic properties of the extracts led instead to the discovery and isolation of two complex indole alkaloids, vinblastine and vincristine, which are used in the clinical treatment of a variety of cancers. The two alkaloids, although structurally almost identical, nevertheless differ markedly in the type of tumors that they affect and in their toxic properties. These and related alkaloids have been the subject of many pharmacological and biochemical investigations both in vivo and in vitro in the search for improved cancer treatments. A model system used in these studies, a transplantable lymphoma in Noble strain rats designated Nb2 node, has serendipitously led to the development of a highly sensitive and specific bioassay for lactogenic hormones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085431

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  68 in total

1.  Almost famous: E. Clark Noble, the common thread in the discovery of insulin and vinblastine.

Authors:  James R Wright
Journal:  CMAJ       Date:  2002-12-10       Impact factor: 8.262

2.  Isolation and characterization of antioxidation enzymes from cells of zedoary (Curcuma zedoaria Roscoe) cultured in a 5-l bioreactor.

Authors:  Nguyen-Hoang Loc; Doan-Thi-Hong Diem; Doan-Huu-Nhat Binh; Dao-Thi Huong; Tae-Geum Kim; Moon-Sik Yang
Journal:  Mol Biotechnol       Date:  2007-11-29       Impact factor: 2.695

Review 3.  SNAREs: cogs and coordinators in signaling and development.

Authors:  Diane C Bassham; Michael R Blatt
Journal:  Plant Physiol       Date:  2008-08       Impact factor: 8.340

4.  Synthesis of a Potent Vinblastine: Rationally Designed Added Benign Complexity.

Authors:  Oliver Allemann; Manuela Brutsch; John C Lukesh; Daniel M Brody; Dale L Boger
Journal:  J Am Chem Soc       Date:  2016-07-01       Impact factor: 15.419

5.  Antileukemic activity of Tillandsia recurvata and some of its cycloartanes.

Authors:  Henry I C Lowe; Ngeh J Toyang; Charah T Watson; Kenneth N N Ayeah; Joseph Bryant
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

6.  Iron(III)/NaBH4-mediated additions to unactivated alkenes: synthesis of novel 20'-vinblastine analogues.

Authors:  Erick K Leggans; Timothy J Barker; Katharine K Duncan; Dale L Boger
Journal:  Org Lett       Date:  2012-02-28       Impact factor: 6.005

7.  Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.

Authors:  Daniel W Carney; John C Lukesh; Daniel M Brody; Manuela M Brütsch; Dale L Boger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-10       Impact factor: 11.205

Review 8.  Clinical pharmacokinetics of vinorelbine.

Authors:  D Levêque; F Jehl
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

9.  Anti-breast cancer potential of frullanolide from Grangea maderaspatana plant by inducing apoptosis.

Authors:  Siriphorn Chimplee; Potchanapond Graidist; Theera Srisawat; Suchada Sukrong; Rassanee Bissanum; Kanyanatt Kanokwiroon
Journal:  Oncol Lett       Date:  2019-04-03       Impact factor: 2.967

10.  Medication contaminants as a potential cause of anaphylaxis to vincristine.

Authors:  David A Hill; Allison Barz Leahy; Joseph Sciasci; Sean P O'Neill; Anne Reilly; Naomi Balamuth; Steven H Seeholzer; Jonathan M Spergel; Terri F Brown-Whitehorn
Journal:  Pediatr Blood Cancer       Date:  2017-08-22       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.